Annual Report

Overview

The report presents EQL Pharma's 2023/24 performance, including Group turnover of SEK 264.2 million and 21 full-time employees. It describes a sustainability strategy linked to seven UN Sustainable Development Goals, with the Board responsible for the sustainability strategy. EQL Pharma also reports a goal to reduce greenhouse-gas emissions by 2027.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: 1 April 2023 – 31 March 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services